Status:
UNKNOWN
German Aortic Valve Registry
Lead Sponsor:
German Aortic Valve Registry
Collaborating Sponsors:
German Society for Thoracic and Cardiovascular Surgery
German Cardiac Society
Conditions:
Aortic Valve Insufficiency
Aortic Valve Stenosis
Eligibility:
All Genders
Brief Summary
1. Research aims The increasing prevalence of severe aortic valve defects is a corollary to increases in life expectancy. For many years, surgical valve replacement with extracorporeal circulation...
Detailed Description
1. Research aims The increasing prevalence of severe aortic valve defects is a corollary to increases in life expectancy (Lindroos et al. 1993). For many years, surgical valve replacement with extrac...
Eligibility Criteria
Inclusion
- All consecutive patients from participating hospitals with aortic valve defects who have received one of the following therapies:
- surgical aortic valve replacement,
- aortic valve surgery (Ross procedure, David procedure)
- percutaneous transvascular (retrograde) aortic valve implantation
- percutaneous transapical aortic valve implantation
- aortic valve valvuloplasty as principal indication. If the aortic valve insufficiency is concurrent with combination procedures (e.g. coronary artery bypass graft, mitral valve surgery) the aortic valve stenosis must fulfil only the criteria for indication according to the German guidelines (Hamm et al. 2008).
Exclusion
- No consent from the patient to collection and analysis of data.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT01165827
Start Date
July 1 2010
End Date
December 1 2022
Last Update
February 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BQS Institute for Quality and Patient Safety
Düsseldorf, North Rhine-Westphalia, Germany, 40472